glp 1 and colonoscopy This randomized clinical trial evaluated the risk of clinically significant residual gastric volume in adults undergoing elective upper endoscopy while receiving glucagon-like peptide-1 (#GLP1) or glucose-dependent insulinotropic polypeptide (GIP GIs clash with GLP-1 restrictions

Scientifically, PT-141 is a cyclic heptapeptide derived from alpha-melanocyte-stimulating hormone (-MSH), specifically targeting the melanocortin-4 receptor (MC4R) to enhance sexual signaling without affecting blood pressure or heart rate like some other treatments.[4] At the most basic level, PT-141 activates brain centers that control sexual desire, increasing blood flow to genital tissues, improving sensitivity, and promoting natural lubricationall without relying on hormonal changes, making it suitable for women who can't or prefer not to use estrogen-based therapies.[4] Its role goes far beyond just sparking interest

Cao H, et al

Genet Genom

"Germline hypomorphic CARD11 mutations in severe atopic disease"